Current Microbiology

, Volume 62, Issue 4, pp 1128–1132

Efficacy of a Broad Host Range Lytic Bacteriophage Against E. coli Adhered to Urothelium

Authors

    • Department of Biological EngineeringUniversity of Minho
  • Dulce Oliveira
    • Department of Biological EngineeringUniversity of Minho
  • Alexandra Moura
    • Department of Biological EngineeringUniversity of Minho
    • Instituto PiagetEscola Superior de Saúde Jean
  • Mariana Henriques
    • Department of Biological EngineeringUniversity of Minho
  • Alberta Faustino
    • São Marcos Hospital
  • Ana Nicolau
    • Department of Biological EngineeringUniversity of Minho
  • Joana Azeredo
    • Department of Biological EngineeringUniversity of Minho
Article

DOI: 10.1007/s00284-010-9834-8

Cite this article as:
Sillankorva, S., Oliveira, D., Moura, A. et al. Curr Microbiol (2011) 62: 1128. doi:10.1007/s00284-010-9834-8

Abstract

Persistent urinary tract infections (UTI) are often caused by E. coli adhered to urothelium. This type of cells is generally recognized as very tolerant to antibiotics which renders difficult the treatment of chronic UTI. This study investigates the use of lytic bacteriophages as alternative antimicrobial agents, particularly the interaction of phages with E. coli adhered to urothelium and specifically determines their efficiency against this type of cells. The bacterial adhesion to urothelium was performed varying the bacterial cell concentrations and the period and conditions (static, shaken) of adhesion. Three collection bacteriophages (T1, T4, and phiX174 like phages) were tested against clinical E. coli isolates and only one was selected for further infection experiments. Based on the lytic spectrum against clinical isolates and its ability to infect the highest number of antibiotic resistant strains, the T1-like bacteriophage was selected. This bacteriophage caused nearly a 45% reduction of the bacterial population after 2 h of treatment. This study provides evidence that bacteriophages are effective in controlling suspended and adhered cells and therefore can be a viable alternative to antibiotics to control urothelium- adhered bacteria.

Introduction

In the recent years, there has been a spread of multidrug resistant bacteria, including bacteria resistant to the last resort antibiotics [1]. Therefore, prevention and control of bacterial resistance requires new antimicrobial agents, the prudent use of existing ones, new vaccines and enhanced public health efforts to reduce transmission of bacterial resistance. Also, the use of bacteriophages as an alternative to antibiotherapy is again redrawing attention. A considerable number of publications demonstrate that phage preparations for veterinary purposes can efficiently control the bacterial loads in infected animals [25] and strongly supports the concept of phage therapy as an alternative or complementary strategy to antibiotherapy. Furthermore, orally administered phages have been recovered from the blood and physical fluids, including urine [6, 7] and phages administered by intraperitoneal injection have been detected in different organs, such as: liver, kidneys, spleen, lungs, muscles, brain, and blood [8]. Despite these attractive characteristics, there is limited information on phage infection of bacteria adhered to epithelial cells. The study described herein focuses the efficacy of phage to kill its target host when the last is found adhered to urothelium. For this, the efficacy of three DSMZ collection phages (T1, T4 and phiX174) against a pool of 69 E. coli strains isolated from urinary tract infections was studied and only the broadest host range phage was used to perform the infection experiments with suspended or urothelium adhered E. coli.

Materials and Methods

Bacteria, Bacteriophage, and Media

The bacteriophages and respective hosts were purchased from the Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ), Germany. Both bacteriophages T1 (DSM 5801) and T4 (DSM 4505) have as host Escherichia coli DSM 613, while phage phiX174 (DSM 4497) has ashost E. coli DSM 13127. The media used for E. coli growth were either LB media or artificial urine (0.65 gl−1 of Magnesium chloride hexahydrate, 0.65 g l−1 of Calcium chloride monohydrated, 4.6 g l−1 of sodium chloride, 2.3 g l−1 of sodium sulfate, 0.65 g l−1 of Sodium Citrate dihydrated, 0.20 g l−1 of Disodium oxalate, 2.8 g l−1 of potassium dihydrogen phosphate, 1.6 g l−1 of potassium chloride, 2.0 g l−1 of NH4Cl, 12 g l−1 of Urea, 1.1 g l−1 of Creatinin, 0.1 g l−1 of Tryptic Soy Broth (TSB)). Phages were propagated in MGC media (5.0 g/l of peptone, 3.0 g/l of meet extract and 0.8 g/l of NaCl). The clinical isolates of E. coli used in this study, were isolated from patients with urinary tract infections.

Lytic Spectra of the Phages and Selection of the Broadest Host Range Phage

The three phages (T1, T4, and phiX174) were tested against the 69 clinical E. coli isolates using the phage spot test procedure [9]. In brief, 3 ml of MGC top-agar (MGC media with 0.6% agar) were added to 100 μl overnight cultures of each clinical isolate and poured onto a dish containing MGC agar (MGC media with 1.2% agar). The agar was allowed to solidify after which 10 μl each phage was spotted on the bacterial lawn of the different isolates. The drop was allowed to dry and the plates were incubated overnight at 37°C. Phage sensitive E. coli showed clear or turbid areas where the phage solutions were spotted.

Antibiotic Sensitivity Test

The susceptibility of the 69 E. coli clinical isolates to eight antimicrobial agents was determined by the disc diffusion method on modified Mueller–Hinton II agar according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST).

Stability of Phage in Artificial Urine

100 μl of T1 phage were added to 400 μl of artificial urine and incubated at 37°C during 24 h. Samples were taken after 0, 3, 6, 9, and 24 h and the phage titre was performed according to Adams [10].

Epithelial Cells and Growth Conditions

Epithelial cell line from human bladder (TCC-SUP from DSMZ) was grown on D-MEM, supplemented with 15% of fetal bovine serum (FBS, Gibco-Invitrogen) and 1% Streptomycin/Penicillin (Gibco-Invitrogen). Cells were grown in 24 well microplates at 37°C and 5% of CO2, until they reached an 80% of confluence. A number of 1 × 105 cells per well, determined by tripan blue exclusion staining, was achieved.

E. coli Adhesion to Epithelial Cells

The TCC-SUP epithelial cell monolayers were washed with phosphate buffered saline (PBS 0.1 M, pH 7.4). After, 500 μl of E. coli 613 diluted suspensions (104 up to 109 CFUml−1) or 500 μl of PBS (control), were added to each monolayer. Adhesion assays were performed during 30, 60, 120, and 180 min, at 37°C and under agitation (120 rpm). At each time point, the wells were washed three times with PBS, to remove unattached bacteria. Bacteria were enumerated by CFU determination, after tripsinization of epithelial cells. All experiments were carried out in triplicate.

Phage Infection of Urothelium Adhered and Suspended Bacteria

Urothelium was grown at 37°C in 24 well ELISA plates until a concentration of 105 cells/well, after which E. coli were allowed to adhere for 2 h. Afterwards, the adhered bacteria were phageinfected during 2 h varying the MOI used (0.1 and 1) and varying also the phage infection conditions (static and dynamic). The plates were incubated at 37°C and the efficacy of phage infection was assessed through determination of the concentration of bacteria. Phage infection of exponential E. coli cultures were also performed in order to compare the lytic efficacy of adhered against suspended E. coli. All experiments were carried out in triplicate.

Results

Antibiotic and Bacteriophage Susceptibility of the 69 Clinical Isolates of E. Coli

The susceptibility of the 69 clinical E. coli isolates is presented in Fig. 1. The resistance profiles of the E. coli clinical isolates revealed that more than 60 percent of the strains were resistant to ampicillin (AMP). Furthermore, the strains were most susceptible to nitrofurantoin (FD) (Fig. 1). Based on these results, the 69 isolates were divided in two groups: the first containing the resistant strains (Fig. 2a) and the second group containing the isolates susceptible to the antibiotics tested (Fig. 2b) and tested for susceptibility to three DSMZ culture collection phages: T1, T4, and phiX174, respectively. Phage T1 showed aptitude to infecting the highest percentage of antibiotic resistant E. coli strains (Fig. 2a) while phage T4 lysed a larger number of antibiotic susceptible isolates (Fig. 2b). Overall the T1 and T4 phages were the most efficient phages showing activity against 43.5 and 41.1% of the clinical isolates tested whereas phage phiX174 exhibited a narrower range of activity, being able to infect only 9.4% of the isolates tested. According to these results, phage T1 was selected for further experiments since it was capable of lysing the broadest range of hosts.
https://static-content.springer.com/image/art%3A10.1007%2Fs00284-010-9834-8/MediaObjects/284_2010_9834_Fig1_HTML.gif
Fig. 1

Susceptibility of the 69 clinical E. coli isolates to 8 antibiotics (AMP ampicillin, NXM norfloxacin, AUG amoxicillin/clavulanate, FD nitrofurantoin, SXT TMP-SMX, CP cephalothin, CIP ciprofloxacin, TET tetracycline)

https://static-content.springer.com/image/art%3A10.1007%2Fs00284-010-9834-8/MediaObjects/284_2010_9834_Fig2_HTML.gif
Fig. 2

Susceptibility of the 69 clinical E. coli isolates to bacteriophage T1, T4, and phiX174. Susceptibility of the: a antibiotic resistant and b antibiotic susceptible strains to phages

Growth of E. coli and Stability of Phage T1 in Urine

The growth characteristics of E. coli DSMZ 613, phage T1’s host, in artificial urine were determined. This bacterium has a doubling time of approximately 53 min and a specific growth rate of 0.78 h−1. Stability tests performed with phage T1 in artificial urine showed that the phage remained stable for 24 h and maintained its infection ability, as confirmed by plaque forming unit tests performed after different periods of exposure to artificial urine (data not shown).

Phage Infection of Bacteria Suspended or Adhered to Urothelium

In vitro phage infection experiments of bacteria adhered to the urothelium were performed under static and dynamic (under the influence of shaking) conditions. Prior to the phage infection experiments on E. coli cells, the phage multiplicity of infection (MOI) was optimized. E. coli were infected, under dynamic conditions (120 rpm), with five different MOIs ranging from 0.01 up to 10 and cell lysis was followed by optical density measurements (data not shown). Two multiplicities of infection were selected for all further experiments: 0.1 and 1, respectively and the infection period selected was 2 h. Furthermore, two different E. coli concentrations which resulted in approximately 105 CFUml−1 of adhered cells after 60 min were also selected for the adhesion and phage infection studies, 106 and 107 CFUml−1, respectively (data not shown). It is important to have this concentration of adhered cells since typically a urinary tract infection is characterized by a positive uroculture of more than 105 CFUml−1[11, 12]. The reduction percentages of bacterial cells adhered to urothelium (A columns in Figs. 3, 4) following phage infection were compared with the reduction values obtained with suspended cultures (S columns in Figs. 3, 4). Under static conditions, cell reductions of both adhered and suspended bacteria following phage infection were in general very low. The use of different MOIs did not influence greatly the average reduction percentages obtained. However, it was clear that phages were slightly more efficient in lysing suspended E. coli than those found adhered to urothelium, independently on the inoculum concentration used. The higher inoculum concentration (107 CFUml−1) resulted in a higher percentage of cell reduction clearly due to the presence of slightly more cells adhered to the urothelium than in the experiments where 106 CFUml−1 was used as inoculum. Although the reduction of adhered cells by phages under static conditions was low, this work evidences that phages can kill to some extent cells adhered to urothelium. Comparatively to the phage experiments carried out under static, under dynamic conditions the phage was significantly more efficient in infecting E. coli adhered to urothelium (Fig. 4). Under static infection conditions, the average cell reduction percentages obtained, using inoculum concentrations of 106 and 107 CFUml−1, were approximately 10 and 20%, while under dynamic conditions those percentages were about 30 and 35% (compare Figs. 3, 4). Furthermore, like in the experiments performed under static conditions, the differences obtained using a MOI of 0.1 and 1.0 were insignificant.
https://static-content.springer.com/image/art%3A10.1007%2Fs00284-010-9834-8/MediaObjects/284_2010_9834_Fig3_HTML.gif
Fig. 3

Percentage of cell reduction after phage infection under static conditions of E. coli suspensions and cells adhered to urothelium using MOIs of 0.1 and 1. Phage infection was performed on bacterial suspensions (S) with two different concentrations (106 and 107 cellsml−1) and on cells adhered (A) to urothelium for 2 h using inoculum concentrations of 106 and 107 cells ml−1

https://static-content.springer.com/image/art%3A10.1007%2Fs00284-010-9834-8/MediaObjects/284_2010_9834_Fig4_HTML.gif
Fig. 4

Percentage of cell reduction after phage infection under dynamic conditions of E. coli suspensions and cells adhered to urothelium using MOIs of 0.1 and 1. Phage infection was performed on bacterial suspensions (S) with two different concentrations (106 and 107 cellsml−1) and on cells adhered (A) to urothelium for 2 h using inoculum concentrations of 106 and 107 cellsml−1

Discussion

Urinary tract infections (UTI) are among the most common bacterial infections affecting a large proportion of the worldwide population. These infections are mainly caused by E. coli that have the capacity to colonize and invade epithelial cells [13]. Presumably, this tactic of invasion allows the development of a cellular niche where microorganism can persist in a protected pathway [14] especially against the action of the antibiotics, as already demonstrated both in vitro and in vivo [15, 16]. In fact, the physiological alterations of bacteria triggered by the sessile mode of live can confer protection against antibiotics [1719]. Specifically it has already been shown that bacteria adhered to epithelium can be up to 100 times more tolerant to antibiotics [19, 20]. In this study the authors describe the use of bacteriophages to reduce the loads of E. coli adhered to urothelium and evaluate their efficacy after infection of cells using two different phage-host ratios and under two distinct conditions, static, and shaken, respectively. The results after the 2 h of phage treatment were similar using an initial MOI of 0.1 or 1 since both phage concentrations led to approximately the same percentage of cell reduction. Furthermore, phage T1 was significantly more efficient in infecting E. coli adhered to urothelium under shaken conditions most likely to an enhancement of the contact between the phage and the respective host. Contrarily to the infection of adhered E. coli, where the efficacy of phage T1 was affected by the application condition used (static or dynamic), the infection of planktonic cells with phage T1 under shaken and non-shaken conditions was comparable. Although in the present study, under static conditions, the adhered bacteria showed to be less sensitive to the phages overall the efficacy of phage T1 against adhered bacteria was similar to the infection of planktonic cells. Thus, contrarily to antibiotics, which hardly remove bacteria from existing biofilms [21], this study shows that phages are able to cause cell lysis of biofilm bacteria.

Besides the ability of phage T1 to infect adhered and planktonic E. coli cultures, this work also shows that phages deposited in culture collection have the ability to kill E. coli from different origins than the deposited host since it was able, together with T4 and phiX174, to infect a variety of antibiotic resistant clinical isolates.

Copyright information

© Springer Science+Business Media, LLC 2010